Gazette.govt.nzPursuant to section 23(4A) of the Medicines Act 1981, the Minister of Health hereby renews the provisional consent to the sale, supply or use in New Zealand of the medicines set out in the Schedule hereto:
Schedule
| Product: | Clomipramine-Teva |
| Active Ingredient: | Clomipramine hydrochloride 10mg |
| Dosage Form: | Film coated tablet |
| New Zealand Sponsor: | Teva Pharma (New Zealand) Limited |
| Manufacturer: | Teva Operations Poland Sp., Krakow, Poland |
|
|
|
| Note: This renewed consent is valid for two years from 10 September 2023. | |
| Product: | Clomipramine-Teva |
| Active Ingredient: | Clomipramine hydrochloride 25mg |
| Dosage Form: | Film coated tablet |
| New Zealand Sponsor: | Teva Pharma (New Zealand) Limited |
| Manufacturer: | Teva Operations Poland Sp., Krakow, Poland |
|
|
|
| Note: This renewed consent is valid for two years from 10 September 2023. | |
Dated this 4th day of September 2023.
DEREK FITZGERALD, Acting Group Manager, Medsafe, Ministry of Health (pursuant to delegation given by the Minister of Health on 11 September 2013).